Winship treats first lung cancer patient with T-cell receptor therapy

$ 21.50

4.6 (165) In stock

Targeting vasoactive intestinal peptide-mediated signaling

Emory Winship Cancer Institute Magazine Fall 2011 by Emory

Letter from Jon Lewin

Winship treats first lung cancer patient with T-cell receptor

Theragenomic medicine: Nivolumab (Opdivo)

Winship Magazine - Spring 2022 by EmoryWeb - Issuu

Engineering strategies to overcome the current roadblocks in CAR T

Optimum health and inhibition of cancer progression by microbiome

Frontiers Strategies to Overcome Failures in T-Cell

History of Winship Winship Cancer Institute

Cancers, Free Full-Text

Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in

AACI Update November 2022

Biomedicines, Free Full-Text

Winship Magazine - Spring 2022 by EmoryWeb - Issuu

Related products

Cost of living: Young cancer patients 'in a desperate situation

Coronavirus and the Cancer Patient - The New York Times

New drug offers hope for pancreatic cancer patients - News and

Israel siege doubles suffering of Gaza children with cancer

Say what? 8 things you shouldn't - or should - say to a cancer patient